Information for this post came from a BBC article.
Mosquitoes carrying the malaria parasite are more attracted to human body odor than uninfected insects, a study suggests.
Researchers found that infected insects were three times more likely to be lured towards a human scent.
The research is published in the journal Plos One.
Videos of hearing and full text of statements can be found here.
On Friday, May 17th, leading global health experts testified to House of Representatives lawmakers during a hearing on the U.S.’s role in combatting malaria globally, agreeing was that the fight against malaria is at a turning point.
The hearing was held by the House Foreign Affairs Subcommittee on Africa, Global Health, Global Human Rights, and International Organizations.
Information for this post came from a BBC article.
Researchers have found a strain of bacteria capable of infecting mosquitos and making them resistant to the parasite that causes malaria.
This study, recently published in the journal Science, showed parasites struggled to survive in infected mosquitoes.
As mosquitos serving as the vector for this deadly disease, the hope is that malaria-resistant mosquitos could reduce cases in humans.
Information for this piece came from a Global Fund press release.
On Friday, the Global Fund to Fight AIDS, Tuberculosis and Malaria announced that it is supporting Uganda in the distribution of over 15.5 million long lasting insecticide-treated nets (LLIN). The campaign will be world’s largest malaria prevention campaign so far this year.
This piece uses information from an article that originally appeared in AllAfrica.
Yesterday, the Gates Foundation announced a $2.9 million grant to Aeras, an nonprofit biotech advancing TB vaccines for the world, the University of Oxford and Okairos, a biopharmaceutical company specializing in T-cell vaccines. This grant will support the collaboration of the three parties to develop vaccines against tuberculosis, HIV and malaria.
Information for this post came from a Digital Journal article.
The US Food and Drug Administration (FDA) has launched a new program aimed at detecting and addressing the burgeoning problem of counterfeit and ineffective malaria drug treatments around the world.
It has been estimated that in parts of sub-Saharan Africa, counterfeit malaria drugs represent one-fifth of the available malaria treatment supplies, with a further two-fifths are substandard.